Vetio Animal Health has been awarded a cannabis research license from Health Canada under the Cannabis Act and Cannabis Regulations, and given the green light to begin development on cannabis-based veterinary drug products in Montreal.

John Kane, CEO of Vetio, commented, “With this license, we are now able to bring Vetio’s expertise to the emerging field of therapeutic cannabis-based products.  We believe that cannabis-based products will be vital to Animal Health, and Vetio is committed to bring solutions to our global partners that are based on science and a disciplined development approach.”

Read the full press release here: